Might life-threatening acute pulmonary edema occur after using recombinant tissue plasminogen activator? A case report

BACKGROUND: Recombinant tissue plasminogen activator (rt-pa) is the first-line drug for the treatment of acute ischemic stroke, and can lead to some complications.There were rare reports of death due to acute pulmonary edema during rt-pa thrombolysis treatment. CASE PRESENTATION: This study reports...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xue-Bing, Qu, Dong, Zhang, Qing, Yue, Xia, Qiao, Dong-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427873/
https://www.ncbi.nlm.nih.gov/pubmed/34503474
http://dx.doi.org/10.1186/s12883-021-02371-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427873/
https://www.ncbi.nlm.nih.gov/pubmed/34503474
http://dx.doi.org/10.1186/s12883-021-02371-w

Ejemplares similares